semaglutide affect birth control and Semaglutide: Drug Interactions So-Called “Ozempic Babies” Raise Questions

You might want to keep this information on a sticky note or in your phone so you can easily reference it when needed

Based on typical regulatory timelines: Phase 3 completion: Late 2026 FDA submission: Late 2026 to early 2027 Earliest possible FDA approval: Mid-to-late 2027 US commercial launch: Early 2028 (projected) If the rollout of semaglutide and tirzepatide taught us anything, it's that demand for these medications consistently outpaces supply in the first year or two

We want you to get the best product for yourself, but if something is not right, do let us know

We follow strict guidelines when it comes to our products

Available: PMID: 38912654